Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers Acquires 100,000 Shares

Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers acquired 100,000 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were purchased at an average price of $0.12 per share, with a total value of $12,000.00. Following the acquisition, the director now owns 2,425,000 shares of the company’s stock, valued at approximately $291,000. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Zomedica Stock Performance

NYSEAMERICAN:ZOM traded up $0.01 during mid-day trading on Tuesday, reaching $0.14. 11,470,186 shares of the company’s stock were exchanged, compared to its average volume of 4,590,538. The firm has a market cap of $134.45 million, a price-to-earnings ratio of -2.05 and a beta of 1.06. Zomedica Corp. has a one year low of $0.12 and a one year high of $0.23.

Wall Street Analysts Forecast Growth

Separately, Noble Financial upgraded shares of Zomedica to a “strong-buy” rating in a report on Monday.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Zomedica stock. Virtu Financial LLC grew its position in shares of Zomedica Corp. (NYSEAMERICAN:ZOM) by 1,585.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 168,773 shares of the company’s stock after acquiring an additional 158,757 shares during the quarter. Virtu Financial LLC’s holdings in Zomedica were worth $25,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 8.95% of the stock is owned by institutional investors and hedge funds.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.